Liver-on-Chip Platforms: Recreating Human Physiology for Predictive Drug Development
Re-Engineering the Liver Microenvironment In the first article of this series, we discussed the limitations of
Adipose Tissue
Liver Organoids in Drug Discovery: 3D Cell Culture Models Transforming Toxicity Testing and Personalized Medicine
The liver organoid is transforming how researchers approach drug discovery and safety testing. As miniature, three-dimensional
Organoids for Lipid Metabolism: Organoid and Organ-on-Chip Models in Metabolic Disease Research
Understanding how the body processes fats is central to tackling obesity, type 2 diabetes, and fatty
Adipose Tissue-on-Chip: Perfused Platforms Driving Next-Gen Metabolic Research
Obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) remain major global health concerns, yet
Adipose Tissue Organoids: Protocols, Applications & Current Limitations
Adipose tissue organoid technology is reshaping metabolic research. From scaffold-free spheroids to hydrogel-based 3D adipose tissue
Understanding Adipose Tissue: A Key to Drug Discovery in Metabolic Disorders
What Does Adipose Tissue Do? Adipose tissue is more than a fat storage site, it’s a
Brown vs White Adipose Tissue: What is at Stake for Pharma
As the global obesity crisis intensifies, the functional aspect of brown adipose vs white adipose tissue
In Vitro Adipose Tissue Models: Organoids, Organs-on-Chip & Next-Generation Platforms
Modern drug discovery is shifting from “one-size-fits-all” animal models toward new-approach methodologies (NAMs) that capture human-specific
How the adipose tissue microenvironment shapes cancer therapy outcomes
The interplay between adipose tissue and therapeutic efficacy is now recognised as a major determinant of clinical
Animal Testing Landscape 2025
About this white paper Animal testing has played a crucial role in medical advancements, leading to
get in touch
Get the best insights about Cherry Biotech by Email
Let’s stay in touch!